Bookmark and Share

Last Minute: "First on CNN: Justice Department willing to hand over counterintelligence if Schiff backs off 'enforcement action' - CNN" Tue, 21 May 2019 18:27:00 GMT    "Investigators to check hospital's actions in case of Marlen Ochoa-Lopez's baby - CNN" Tue, 21 May 2019 22:02:00 GMT    "Pelosi's Strategy Is Working, And Trump Is One Step Closer to Being F*cked - Daily Beast" Tue, 21 May 2019 20:05:00 GMT    "House Democrat Announces Plan to (Deep Breath) Introduce Inquiry Into Investigating Whether to Consider Impeachment - Slate" Tue, 21 May 2019 16:30:00 GMT    "Investigation into Virginia Gov. Ralph Northam's yearbook photo concludes - Washington Examiner" Tue, 21 May 2019 16:23:00 GMT    "US intercepts Russian fighter jets and bombers off Alaska - Washington Examiner" Tue, 21 May 2019 16:23:00 GMT   "House panel issues subpoenas for Hope Hicks, Annie Donaldson - CNN" Tue, 21 May 2019 20:41:00 GMT    "Because Of Trump Pardon Threats, New York Plugs 'Double Jeopardy' Loophole - NPR" Tue, 21 May 2019 21:09:00 GMT    "Majority of Americans don't want Roe v. Wade overturned, CBS News poll finds - CBS News" Tue, 21 May 2019 21:00:00 GMT    "Theresa May offers Parliament a vote on a second Brexit referendum - The Washington Post" Tue, 21 May 2019 18:42:49 GMT      For more news, click here.

Authentication
       
       
Remember me? 

Fall of
--0.85 (+0.98%) Pfizer - [Ticker: PFE]Chart Pfizer  News Pfizer  Download Historical Prices for Metastock Pfizer and Others  Technical Analysis Pfizer  
Last Trade45.14Last Trade Time2018-12-04 - 00:00:00
Variation--0.85 (+0.98%)Open46.23
High46.47Low45.11
Volume26,062,310Average Volume (3m)0
YieldBid / Ask35.33 x 5,700 - 35.34 x 8,100
Former Close45.9952 Week Range[0.00 - 0.00]
PER0.00%EPS0.00
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Pfizer -  [Ticker: PFE] chart
Change to Pfizer Interactive Technical Analysis Chart

Last 10 Forum Topics about Pfizer:
No topics about Pfizer [PFE] have been found, but a search on the Forum for more topics related to Pfizer is advised.

 News about Pfizer [PFE]:   (ordered by relevance)
Pfizer: Added Value For A Defensive Pharma Portfolio  Seeking Alpha

Of the 6 largest pharmaceutical companies by market cap, Pfizer is the most balanced and with the shallowest patent cliff. Its best selling drugs are immune to.

Pfizer: A 3.5% Yield, But Lyrica's Patent Loss Keeps Me From Buying  Seeking Alpha

Pfizer Inc. is a global biopharma giant with a 3.5% dividend yield and a broad portfolio of therapies and consumer healthcare products. Pfizer has invested in R.

Pfizer Nabs Regulatory Approval For Tafamidis, An FDA First Is Achieved  Seeking Alpha

Pfizer obtained FDA approval for drugs Vyndaqel and Vyndamax to treat patients with transthyretin amyloid cardiomyopathy. Vyndaqel and Vyndamax are the ...

Better Buy: AbbVie vs. Pfizer  Motley Fool

AbbVie and Pfizer are both undergoing a radical makeover. Which company should investors trust to come out even stronger?

Pfizer Inc (PFE) Q1 2019 Earnings Call Transcript  Motley Fool

PFE earnings call for the period ending March 31, 2019.

Where Will Pfizer Be in 5 Years?  Motley Fool

The last five years were good for Pfizer shareholders. Here's how the next five could be different.

Better Buy: Eli Lilly vs. Pfizer  The Motley Fool

If you're looking to add a big pharma stock to your portfolio, Eli Lilly (NYSE:LLY) and Pfizer (NYSE:PFE) are naturally two top candidates. Both big drugmakers ...

Google sister-company Verily is teaming with big pharma on clinical trials  CNBC

Verily, Alphabet's health and life sciences division, is moving into the clinical trials market. It just announced strategic alliances with Novartis, Sanofi, Otsuka and ...

Pfizer Acquires Therachon, Looks To Add To Rare Disease Pipeline  Seeking Alpha

Pfizer acquires private biotech Therachon to gain a clinical product, known as TA-46, to treat patients with Achondroplasia. Pfizer paid an upfront payment of $

Pfizer Denies Encouraging Drug Abuse By Packaging Fentanyl With Cooking Spoon, Lighter  The Onion

NEW YORK?In an effort to address the growing controversy surrounding widespread non-medical use of their products, pharmaceutical giant Pfizer released a ...

Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock  Investorplace.com

Buy Pfizer stock on this current round of weakness. As Credit Suisse knows, the underpinnings are bullish for 2020 and beyond.

FDA OKs expanded use of Pfizer's anticoagulant Fragmin  Seeking Alpha

The FDA has approved Pfizer's (PFE +1.2%) Fragmin (dalteparin sodium) injection to reduce the recurrence of symptomatic venous thromboembolism (VTE) in ...

Pfizer Stock: Is It A Buy Right Now? Here's What Earnings, PFE Chart Show  Investor's Business Daily

Pfizer stock has fallen harder than other drug makers this year. News has been upbeat with a drug approval and earnings beat. Is Pfizer a buy right now?

Pfizer?s Pipeline Makes Progress as Sales Grow  The Wall Street Journal

Pfizer's new portfolio of prescription drugs lifted sales during the first quarter as the company said it continues to make progress on growing through its internal ...

Pfizer Beats In Q1 But Lyrica Headwinds Will Likely Weigh On Near Term Growth  Forbes

Pfizer (NYSE:PFE) recently reported its Q1 2019 results, which were above our estimates. This note details the company's Q1 performance, and Trefis' forecast ...

Can Pfizer Leap Over the Competition With This Potential Blockbuster?  Motley Fool

It's been nearly seven years since the FDA refused to approve tafamidis' first new drug application, and the field is a lot more crowded now.

Pfizer Gains After Being Named 'Top Pick' by Credit Suisse  TheStreet.com

Shares of Pfizer (PFE - Get Report) posted gains on Thursday after the drugmaker was named a "top pick" at Credit Suisse following a meeting the analysts had ...

Pfizer to Showcase Data from Innovative Science at 2019 Annual ASCO Meeting  OncoZine

Data from 10 therapies across 10 types of cancer mechanisms of action highlighting Pfizer's cutting-edge approach, expertise in precision medicine and work in ...

Pfizer shareholder meeting offers inside look at the pharma industry  STAT

As Pfizer's board and shareholders celebrate stunning revenue and profits, it's time to ask why it's drugs cost so much. High R&D isn't the answer.

Teva, Pfizer, Sandoz among 20 companies accused of illegally hiking generic drug prices  NorthJersey.com

Federal authorities say 20 companies, including Teva, Sandoz and Pfizer, illegally conspired to hike generic drug prices.

Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs  Zacks.com

FDA grants approval for line extensions of Lilly (LLY), Pfizer (PFE) and Roche (RHHBY)/AbbVie's (ABBV) cancer drugs.

Insurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For It  Forbes

It's unclear whether health insurers and PBMs will cover Pfizer's $225000 a year drug tafamidis to treat a rare heart disease.

It?s Far Too Soon To Give Up On Pfizer Inc. (PFE), Anadarko Petroleum Corporation (APC)  Post Analyst

Pfizer Inc. (NYSE:PFE) attracted a higher number of shares in volume with 27611039 contracts traded on 19-May-19. However, its trading capacity stayed ...

Sosei nabs $3M milestone from Pfizer under drug discovery partnership  Seeking Alpha

Sosei Group (OTCPK:SOLTF) announces that it has earned a $3M milestone payment from collaboration partner Pfizer (PFE +1.3%) triggered by certain ...

Pfizer touts late-stage win for JAK drug that could duel with Dupixent  BioPharma Dive

Pfizer said Wednesday its experimental JAK1 inhibitor succeeded in a pivotal eczema study, although safety questions remain largely unanswered in a sparse ...

Here are the biggest analyst calls of the day: Macy's, Pfizer, Owens Corning & more  Yahoo Finance

Here are the biggest calls on Wall Street on Thursday: Goldman Sachs upgraded Macy's to 'neutral' from 'sell'. Goldman said the underperformance of the stock ...

Pfizer Lifts 2019 Earnings Forecast as Biopharma Sales Drive Q1 Profit Beat  TheStreet.com

Pfizer posted stronger-than-expected first quarter earnings Tuesday, and boosted the mid-point of its full-year profit forecast thanks to anticipated gains in ...

Pfizer gets U.S. approval for $225,000 a year heart drug  Reuters

NEW YORK (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer Inc's oral drug, tafamidis, to treat a rare and fatal heart disease ...

The Factor Everyone Ignores: UP Fintech Holding Limited (TIGR), Pfizer Inc. (PFE)  Post Analyst

UP Fintech Holding Limited (NASDAQ:TIGR) has a price-to-sales ratio of 26.92, well above its Application Software competitors. For the industry, the average ...

The Zacks Analyst Blog Highlights: Teva, Mylan, Novartis and Pfizer  Yahoo Finance

For Immediate Release. Chicago, IL ?May 15, 2019 ? Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research ...

Latest Change: Pfizer (NYSE: PFE)  TNN

Pfizer is in the drug manufacturers industry and is in the healthcare sector. The company CEO is Albert Bourla. Pfizer Inc is a biopharmaceutical company that ...

Pfizer jumps into the heated PhIII race for new-wave JAK inhibitors ? but safety frets loom large  Endpoints News

Pfizer has racked up a positive slate of Phase III data for its anti-?inflammatory JAK1 inhibitor abrocitinib (PF-?04965842), which the pharma giant is hoping to ...

Pfizer (PFE) to Report Q1 Earnings: Will It Beat Estimates?  Zacks.com

While Pfizer's (PFE) key drugs like Ibrance and Xeljanz are likely to drive Q1 sales, genericization of key drugs and weak sales in the EH segment will hurt.

Top vaccine makers Merck and Pfizer target China and older adults next  CNBC

Four giant companies now dominate global vaccine sales. With newer and more expensive vaccines becoming available, the market value of vaccines could ...

Better Buy: Pfizer vs. AbbVie  Yahoo Finance

Pfizer (NYSE: PFE) and AbbVie (NYSE: ABBV) rank as two of the largest and most successful drugmakers on the planet. The two companies are leaders in ...

Which Stock will you hold for a while? Pfizer, Inc. (NYSE:PFE), Proofpoint, Inc. (NASDAQ:PFPT)  The Newburgh Press

Pfizer, Inc. (NYSE:PFE) Pfizer, Inc. (NYSE:PFE), ended its previous trading session at $41.59 showing a gain of 0.120000000000005 or 0.29 percent with ...

Eli Lilly, Merck, and Pfizer Earnings Are Coming. Here?s What to Watch.  Barron's

The three big pharmaceutical companies ? Eli Lilly, Merck, and Pfizer ? are due to release their results on Tuesday. Although health care had a fairly good ...

Risk-Based Monitoring: Pfizer and BMS Seek Clarity on FDA Draft Guidance  Regulatory Focus

Pfizer and Bristol-Myers Squibb (BMS) recently raised questions with and sought further clarity from the US Food and Drug Administration (FDA) on a draft ...

Pfizer to buy Therachon for $340M, taking on BioMarin, Ascendis  BioPharma Dive

Pfizer will pay $340 million upfront to acquire a private biotech, taking over development of an experimental dwarfism therapy that will pit the giant drugmaker ...

Pfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain Management  Forbes

Pfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have all joined the MediLedger Project Contracting and Chargebacks ...

Stocks making the biggest moves premarket: Walmart, Pfizer, PG&E, Sony, Tesla & more  CNBC

Check out the companies making headlines before the bell: Walmart ? The retail giant reported adjusted quarterly profit of $1.13 per share, 11 cents a share ...

Sarepta: Buy The Pfizer Selloff  Seeking Alpha

Pfizer's upcoming data reveal created a perfect sell the news event for Sarepta. The road to DMD drug greatness is strewn with failures as Pfizer has a lot to p.

Pfizer Executive: Technology Is ?Basically Good Enough? to Ramp Up Production Blockchains  Cointelegraph

A Pfizer executive has challenged existing theories about slow rates of blockchain adoption ? telling the Consensus conference on May 14 that the technology ...

Top Stock Reports for Pfizer, Intel & HCA Healthcare  Yahoo Finance

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, ...

Pfizer opens $200m clinical manufacturing plant in MA  BioProcess Insider

The multiproduct facility will support early-phase manufacturing for its biologics pipeline, Pfizer says. Last week, pharma giant Pfizer cut the ribbon on the latest ...

Pfizer's Eczema Candidate Meets All Goals in Phase III Study  Yahoo Finance

Pfizer's (PFE) investigational eczema treatment abrocitinib succeeds in pivotal late-stage study.

Ride Out The Next Market Storm With Sempra Energy (SRE), Pfizer Inc. (PFE)  Financial Mercury

The shares of Sempra Energy (NYSE:SRE) has been pegged with a rating of Buy by BofA/Merrill in its latest research note that was published on October 11th, ...

Pfizer unveils new manufacturing facility | News  Andover Townsman

A ribbon-cutting ceremony held last Thursday morning celebrated Pfizer's new 175000-square-foot clinical manufacturing facility at the company's campus on ...

Merck, Pfizer Stock Rise, Lilly Slips as Big Pharma Earnings Roll In  Barron's

Both Merck stock and Pfizer stock are were on the rise Tuesday morning after reporting first-quarter earnings, while Eli Lilly stock slipped into the red following ...

Why Earnings Season Could Be Great for Pfizer (PFE)  Zacks.com

Pfizer (PFE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

BRIEF-Verily Forms Strategic Alliances With Novartis, Otsuka, Pfizer And Sanofi To Transform Clinical Research  Reuters

May 21 (Reuters) - Verily, Novartis, Otsuka, Pfizer And Sanofi: * VERILY FORMS STRATEGIC ALLIANCES WITH NOVARTIS, OTSUKA, PFIZER AND SANOFI ...

5 Reasons Why Pfizer Is a Great Stock to Buy and Hold for the Long Term  The Motley Fool

A few bumps in the road might be on the way, but this big pharma stock should have pretty smooth sailing over the next decade.

How Viagra revolutionized the erectile dysfunction market  CNBC

Despite competition from other drugmakers, Pfizer has been able to maintain a significant share in the erectile dysfunction market thanks in part to launching its ...

Laffer Investments Has Trimmed Its Holding in Pfizer (PFE) by $8.51 Million as Share Price Declined; Northrop Grumman (NOC) Holder Strategic Global Advisors Has Trimmed Its Position by $342,088 as Stock Rose  The EN Herald

Laffer Investments decreased its stake in Pfizer Inc (PFE) by 1.09% based on its latest 2018Q4 regulatory filing with the SEC. Laffer Investments sold 195 ...

What Are Analysts Recommending for PFE after Q1 Results?  Market Realist

On April 30, Pfizer (PFE) reported first-quarter results. The company reported revenues of $13.12 billion in the first quarter, a YoY rise of 2% on a reported basis ...

The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins  Yahoo Finance

For Immediate Release. Chicago, IL ? May 6, 2019 ? Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research ...

Brainstorm Health: Royal Baby, All of Us, Pfizer Heart Drug Approval  Fortune

Happy Monday, readers. I hope you've had a wonderful weekend. Alright, I'll come clean up top? This sort of is about the royal baby. But only as a point of ...

Updated: Pfizer Calls for Compromise on Retroactively Using Suffixes in Biologic Names  Regulatory Focus

In response to the US Food and Drug Administration's (FDA) proposal to not go back and rename certain biologics with nonsense suffixes, as it once said it ...

Pfizer (PFE) Holder Beacon Financial Group Decreased Position; Applied Matls (AMAT) Market Valuation Rose While Global Endowment Management LP Decreased Its Stake  The EN Herald

Beacon Financial Group decreased its stake in Pfizer Inc (PFE) by 47.99% based on its latest 2018Q4 regulatory filing with the SEC. Beacon Financial Group ...

Rickets Market Trend 2019 by Companies Pfizer, Abbott, Koninklijke DSM  The Edge

A new market study, titled ?Discover Global Rickets Market Upcoming Trends, Growth Drivers and Challenges? has been featured on ...

Pfizer profit jumps 9% on higher sales, lower costs  Champaign/Urbana News-Gazette

Higher prescription drugs sales and restrained spending together gave drugmaker Pfizer a 9% jump in first quarter profit as it easily topped analysts' profit ...

Women Health- Market Future Growth and Forecast with Significant Players Pfizer Inc., Merck & Co., Sanofi, Eli Lilly and Company  The Market Bureau

Profound analysis of Global Women Health Market based on opportunities, risks, growth-boosting factors, and restraints. The Global Women Health Market ...

Pfizer stock up 1.7% after earnings and revenue beat  MarketWatch

Shares of Pfizer rose 1.7% in premarket trade Tuesday after the company reported first-quarter earnings and revenue that beat expectations, while raising its...

Pneumococcal Vaccines Global Market 2019-2024: Merck & Co. Inc., Pfizer Inc., GlaxoSmithKline Plc., Sanofi Pasteur, Astellas Pharma Inc  The Market Bureau

Profound analysis of Global Pneumococcal Vaccines Market based on opportunities, risks, growth-boosting factors, and restraints. The Global Pneumococcal ...

Pfizer urges FDA for flexibility in considering interchangeability studies  BioProcess Insider

The US FDA has published long-awaited final guidance on the interchangeability of biologics, calling biosimilar developers to carry out switching studies.

Former Pfizer Inc. Executive Joins Applied Biosciences as CEO  The DMO

In January, just a few weeks after the passing of the 2018 Farm Bill, Applied Biosciences Corp. (OTC:APPB) added a major player from the pharmaceutical ...

Health Care Sector Update for 05/21/2019: BCRX, MNK, BIOC, JNJ, PFE, ABT, MRK, AMGN  Nasdaq

Top Health Care Stocks:JNJ: FlatPFE: +0.38%ABT: +0.30%MRK: -0.20%AMGN: +1.23%Health care majors were mixed in Tuesday pre-market trading .Early.

AstraZeneca chief claims vindication five years after Pfizer bid  Financial Times

Five years ago this week, AstraZeneca boss Pascal Soriot was embarking on the fight of his life. The urbane Frenchman, who learned how to hold his own ...

Chuck the ChapStick: Ditch the Lip Balm Until Pfizer Quits Its Cruelty  PETA

It's time to kiss ChapStick goodbye. Pharmaceutical kingpin Pfizer?maker of ChapStick lip balm?has refused to ban a cruel and useless animal experiment that ...

Can Pfizer Inc. (NYSE:PFE) Continue To Move The Needle? Shares to Grow 4.50%  Glenwood Guardian

Analysts are projecting Pfizer Inc. (NYSE:PFE) to grow at an accelerated rate over the next five years. Sell-side analysts are looking for the.

Pfizer Hosts Annual Meeting of Shareholders  Yahoo Finance

The board of directors of Pfizer Inc. today declared a 36-cent second-quarter 2019 dividend on the company's common stock, payable June 7, 2019 to ...

Global Tuberculosis Drugs Market Top Player 2019 ? Pfizer Inc, Lupin Laboratories Ltd, AstraZeneca Plc  World Wide Report

Market Research always aims at offering their clients an in-depth analysis and the best research material of the various market. This new report on the ...

SuperTrend Higher Than Share Price for Pfizer Inc (PFE)  Hermann Herald

Traders might be taking a second look at shares of Pfizer Inc (PFE). After a recent spotcheck, we can see that the SuperTrend line is now above the current.

Healthcare Transformer 2019: Lidia Fonseca, Pfizer - Top 40 Transformers - MM&M  Medical Marketing and Media

You might say Lidia Fonseca has been solving problems since she was a little girl. Born in Mexico, Fonseca moved to the U.S. when she was 10. ?I learned to ...

Antiandrogen Monotherapy Market Latest Technology Trends Analysis by World | Pfizer, Abbott Laboratories, Genentech, GlaxoSmithKline Plc (UK), Immunomedics, Indevus Pharmaceuticals, Novartis AG , OSI Pharmaceuticals, and Paladin Labs  Healthcare News

Global Antiandrogen Monotherapy Market is expected to huge growth during forecast period 2019 to 2025. Antiandrogen Monotherapy are highly demanded in ...

Tom Miller, Iowa's attorney general, joins multi-state lawsuit against Teva, Pfizer over inflated drug prices  Des Moines Register

It's unclear whether the lawsuit would be affected by a bill that would limit the attorney general's power to join out-of-state cases.

GSK-Pfizer deal gets approval from Australia's anti-trust watchdog  Reuters

(Reuters) - GlaxoSmithKline's deal to buy Pfizer's consumer healthcare business will not lesson competition in Australia, the country's anti-trust regulator said on ...

Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of One Lot of ThermaCareŽ Back Pain Therapy HeatWraps, up to 16HR pain relief, Due To Out of Specification Results for High Cell Temperature  FDA.gov

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public *service*. FDA does not endorse ...

Pfizer prospects for tafamidis market  BioPharma Dive

Pfizer expects the Food and Drug Administration to decide in July on approval of tafamidis in the rare disease transthyretin amyloid cardiomyopathy. Assuming ...

Pfizer Stock Suffers From an Underappreciated Drugs Pipeline  Investorplace.com

PFE stock hasn't been a terribly rewarding name to own since the middle of last year, but Pfizer is doing everything it's supposed to do.

Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod  Zacks.com

Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.

Safety setback for Pfizer, Lilly pain drug should have Regeneron and Teva feeling nervous  BioPharma Dive

Pfizer and Eli Lilly last week reported their experimental pain drug tanezumab increased rates of osteoarthritis and other skeletal side effects in a Phase 3 trial ...

Highlighted Analyst Calls For Pfizer Inc. (PFE), Barrick Gold Corporation (GOLD)  Financial Mercury

Looking at top Wall Street opinions, Pfizer Inc. (NYSE: PFE) has recently made its way into the research list of Citigroup ? signaling that their analyst's rating ...

Global Thyroid Gland Disorder Treatment Market 2019 ? Pfizer, Abbott, RLC LABS, Allergan, Merck Sharp Dohme  Market News 24

Global Thyroid Gland Disorder Treatment Market Research Report comprises holistic business information and changing trends in the market that enables users ...

Global Patent Medicine Market 2019 ? Pfizer Inc., Otsuka Pharmaceutical, Merck, Novartis, Sanofi-Aventis  Worldwide Market

Innovate Insights conferred analysis report on Global Patent Medicine Market 2019 by implementing an exquisite analysis procedure to assemble key ...

Investors are Focusing on These Shares: Pfizer Inc. (NYSE:PFE)  Hermann Herald

Sharp investors are usually looking for true bargains in the stock market. Finding these stocks can help give the stock portfolio a boost. Shares of Pfizer Inc.

EU regulators slap safety restriction on Pfizer's Xeljanz  pharmaphorum

European safety regulators have placed restrictions on Pfizer's Xeljanz, saying it should not be used in the higher dose used in patients with ulcerative colitis ...

Benefits to hold this: Pfizer Inc. (NYSE:PFE), Extraction Oil & Gas, Inc. (NASDAQ:XOG)  Alpha finews

On 05-21-2019 (Monday), Shares of Pfizer Inc. (NYSE:PFE) encountered a difference of 0.29% after which it shut the day' session at $41.59. The volume added ...

Barrow Hanley Mewhinney & Strauss Has Lowered Ofg Bancorp (OFG) Stake By $1.56 Million; Pitcairn Company Has Lifted Pfizer (PFE) Stake  The EN Herald

Barrow Hanley Mewhinney & Strauss Llc decreased Ofg Bancorp (OFG) stake by 24.37% reported in 2018Q4 SEC filing. Barrow Hanley Mewhinney & Strauss ...

Pfizer Oncology to Showcase New Data from Innovative Science That Address Patient Needs at ASCO 2019 Annual Meeting  Yahoo Finance

NEW YORK--(BUSINESS WIRE)--. Data spans 10 therapies across 10 types of cancer. Pfizer Inc. (PFE) will present data across its industry-leading oncology ...

Pfizer marks 50th anniversary of arrival in Ireland  The Irish Times

US multinational initially made citric acid at a plant in Ringaskiddy, Co Cork.

Pfizer' Talzenna leads latest CHMP highlights  PharmaTimes

Thirteen medicines were recommended for approval at the committee's April 2019 meeting. - News - PharmaTimes.

Global Cetirizine Hydrochloride Market Insights 2019-2026- UCB Pharma, Pfizer, J & J, Mylan, Teva, HUAPONT Pharm  The Industry Updates

The ?Cetirizine Hydrochloride Market? report offers a thorough examination of the diverse patterns and factors affecting the development direction of the ...

What happened to Viagra after Pfizer's patent for the 'wonder pill' expired  Yahoo Finance

Initially used to treat high-blood pressure, Viagra was introduced to the erectile dysfunction market in the late 1990s. It has averaged sales of over a billion ...

Pfizer, Merck KGaA's latest Bavencio nod sets up 3-way kidney cancer battle  FiercePharma

The FDA approved Pfizer and Merck KGaA's Bavencio in combination with Inlyta for the first-line treatment of patients with advanced kidney cancer. (Pfizer).

Pfizer oncology R&D exec heads to Aduro as new CMO; Army dumps Tonix research contract  Endpoints News

A troubled Aduro has recruited a Pfizer cancer R&D exec to take the chief medical officer's job. Dimitry S.A. Nuyten is moving from his job as Vice President and ...

Parnassus Investments Increased Fedex Corp. (FDX) Holding By $7.08 Million; Pfizer (PFE)'s Sentiment Is 0.74  The EN Herald

Parnassus Investments increased Fedex Corp. (FDX) stake by 51.7% reported in 2018Q4 SEC filing. Parnassus Investments acquired 43946 shares as Fedex ...

Global Oncology Biosimilars Market Outlook 2019-2026: Celltrion Inc., Pfizer Inc., Biocon, BIOCAD, Apotex Inc., Dr. Reddy?s  News Earlier

The ?Oncology Biosimilars Market? has its complete summary provided in such a pattern that the reading is enough to get the gist of the vital information ...

Pfizer (PFE) Holder Capital Investment Advisors Has Lowered Its Stake by $1.57 Million; Harvey Capital Management Position In Celgene (CELG) Was Upped  CryptoCoinsTribune

Capital Investment Advisors Llc decreased its stake in Pfizer Incorporated (PFE) by 8.37% based on its latest 2018Q4 regulatory filing with the SEC. Capital ...

Pfizer Inc. (NYSE:PFE) Shares Bought by Genovese Burford & Brothers Wealth & Retirement Plan Management LLC  Tech Know Bits

Genovese Burford & Brothers Wealth & Retirement Plan Management LLC boosted its position in Pfizer Inc. (NYSE:PFE) by 36.6% in the 4th quarter, according ...

For more news about Pfizer click here:
Pfizer News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2019 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources